This inventor holds 4 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 3 EPO patents. Top assignee: Actinium Pharmaceuticals, Limited. Active years: 2012-2017.
Company Filing History:
Years Active: 2012-2017
Title: Eva Kabai: A Pioneer in Radioisotope Purification
Introduction
Eva Kabai, an accomplished inventor based in Eching, Germany, has made significant contributions to the field of radioisotope purification. With a total of four patents to her name, she has developed innovative methods that enhance the efficiency and safety of radioisotope extraction for pharmaceutical applications.
Latest Patents
One of her notable inventions is a method for the purification of 225Ac from irradiated 226Ra-targets. This groundbreaking method involves a leaching treatment of the Ra-targets using nitric or hydrochloric acid, effectively extracting both Ac and Ra. The process is followed by a series of extraction chromatography steps, which separate Ac from Ra and other isotopes, including Po and Pb. The purified Ac has significant potential for use in preparing pharmaceutical compositions, highlighting its importance in medical applications.
Career Highlights
Eva currently works at Actinium Pharmaceuticals, Limited, where she focuses on advancing the purification processes of radioactive elements. Her innovative approaches have proven crucial in the development of treatments that leverage the unique properties of radioisotopes, showcasing her dedication to improving healthcare.
Collaborations
Throughout her career, Eva has collaborated with several professionals, including Josue Manuel Moreno Bermudez and Richard Henkelmann. These partnerships have allowed her to enhance her research, driving forward the field of radioisotope purification with collaborative innovation.
Conclusion
Eva Kabai stands out as a prominent figure in the realm of radioisotope purification. Her latest patents and contributions to Actinium Pharmaceuticals affirm her role as an innovator in pharmaceutical applications of radioisotopes. As she continues to refine her methods and cooperate with fellow researchers, the impact of her work is poised to advance medical technologies significantly.